Patent ID: 8512717
Filing Date: 2013-08-20
Classification: A61K,A61P

Abstract:
1. A topical ophthalmic solution for administering an anti-inflammatory to a human or animal suffering from ophthalmic inflammation, the solution consisting of: water; ketorolac, in a range of 0.01% to 1.0% w/v; a retention component in an amount effective to provide the topical ophthalmic composition with a viscosity greater than human tear fluid wherein the retention component consists of a mixture of medium molecular weight carboxymethyl cellulose and high molecular weight carboxymethyl cellulose wherein the medium and high molecular weight carboxymethyl cellulose have a weight ratio between 0.25 and 4 and is present in an amount of 0.1% to 2.0% w/v; sodium hydroxide and hydrochloric acid to adjust the pH; sodium chloride; a buffer; and having a pH in a range of about 6 to about 8.